Related Experiment Videos
[Solitary nasal plasmocytoma]
F Giménez Vaíllo1, V Cortés Vizcaíno, A López Rodríguez
1Servicio de Otorrinolaringología, Hospital Gran vía, Castellón.
Abstract:
Report of the case of one patient diagnosed of a nasal extramedullary solitary plasmacytoma, starting as an suppurated panophtalmia. Biopsy of the mass inside the nose led to diagnosis. Comments about the difficulties of histopathological differential diagnosis, underlying the need to rule out any other systemic process (multiple myeloma). The subject was treated with inductive chemotherapy and radiotherapy, being free of the illness after 4 years follow up.
Insights
Nasal extramedullary solitary plasmacytoma, a rare plasma cell tumor, was diagnosed in a patient presenting with panophthalmia. Successful treatment involved chemotherapy and radiotherapy, leading to a 4-year disease-free survival.
Area of Science:
- Oncology
- Ophthalmology
- Pathology
Background:
- Extramedullary plasmacytomas are rare plasma cell neoplasms.
- Nasal involvement is uncommon, presenting diagnostic challenges.
Observation:
- A patient presented with suppurative panophthalmia, later diagnosed as nasal extramedullary solitary plasmacytoma via biopsy.
- Histopathological differential diagnosis was complex, requiring exclusion of systemic disease.
Findings:
- Nasal extramedullary solitary plasmacytoma can manifest with ocular symptoms.
- Accurate histopathological diagnosis is crucial to differentiate from multiple myeloma.
Implications:
- Early diagnosis and multidisciplinary treatment are key for favorable outcomes.
- This case highlights the importance of considering rare tumors in complex presentations.